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Objective. This was a comparative study between FNAC and thyroid scan used to diagnose the solitary thyroid nodule and
histopathology was used as gold standard to compare the results of both modalities. We hypothesized that Fine needle aspiration
cytology and thyroid scan diagnose solitary thyroid nodule (STN) as accurately as histopathology. Materials and Methods.T h i s
study comprised of 50 patients with solitary thyroid nodules (STN) presented to OPD. After clinical examination these patients
were referred to Centre for Nuclear Medicine, Mayo Hospital Lahore for thyroid function tests and thyroid scan (TS). These
patients underwent FNAC in the department of Pathology and surgery in Mayo Hospital. The cases were operated and evaluated
forhistopathologicalchanges.Results.Onthyroidscan,40patients(80%)havingcoldnodulewerelabeled assuspicious10patients
(20%) had hot nodule. On FNAC 23 patients (46%) had benign lesion,22 patients (44%) had indeterminate lesion and 5 patients
(10%) had malignant lesions. On histopathology, 45 patients (90%) were conﬁrmed to have benign lesions and 5 patients (10%),
malignant lesions. After comparison of results of thyroid scan and FNAC with histopathology, the sensitivity, speciﬁcity, positive
predictive value,negative predictive valueanddiagnosticaccuracyofthyroidscanwere 80%,20%,10%,90%and26%,respectively
whereas thoseofFNAC were 80%,97.7%,80%,97.7%and96%,respectively. Conclusion.Fine needle aspirationwasa signiﬁcantly
better predictor of malignancy than thyroid scan and resulted in a smaller proportion of excisions for benign nodules.
1.Introduction
Thyroid nodular (TN) lesions are a common clinical prob-
l e mi nt h ew o r l d .T h e s ea r em o r ec o m m o ni nw o m e na n d
in areas of iodine deﬁciency. Exposure to ionizing radiation
in childhood and adolescence increases the risk of solitary
thyroid nodule and thyroid carcinoma. In the United States,
4to7%oftheadultpopulationhasapalpablethyroidnodule
[1].
A solitary thyroid nodule isa palpableswelling in thyroid
gland that has otherwise a normal appearance [2]. The
majority of thyroid nodules are asymptomatic and only
about 5 percent of all palpable nodules are found to be
malignant. A variety of tests have been employed to separate
benign from malignant thyroid nodules [2, 3].
These tests includeisotopescanning andﬁne needle aspi-
ration cytology. Combined use of isotope scanning, ﬁne
needle aspiration cytology, and histopathology of thyroid
oﬀers the best diagnostic strategy [4].
Isotope scanning was generally used to classify nodules
into nonfunctioning (cold) or functioning (warm or hot)
nodules. The scans used either Iodine123 or technetium
Tc99m pertechnetate. Only 5 to 15% of the cold nodules are
malignant [1, 5].
As the cost of 131 scintigraphy increases, the I-131
scintigraphy becomes less eﬀective than the ﬁne needle aspi-
ration cytology strategy. In one study of solitary thyroid
nodule, the speciﬁcity of scan turns out to be only 21.1%.
So advice is there to avoid this technique as a routine test in
patients with nontoxic thyroid nodules [6, 7] (6, 8).
Fine needle aspiration cytology of thyroid nodules is the
single most sensitive, speciﬁc, and cost-eﬀective method of
investigation of thyroid nodules. Now it is safely and widely
recommended for the preoperative selection of patients.2 Pathology Research International
The major pitfall of this procedure is that ﬁne needle
aspiration cytology cannot diﬀerentiate between follicular
adenoma and follicular carcinoma [5, 7].
Histopathology of the excised specimen showed multin-
odular goiter as the commonest lesion. In one study, ﬁne
needle aspiration cytology and thyroid scan oﬀers the best
preoperative assessment of solitary thyroid nodule. Histo-
pathology later on conﬁrms the preoperative diagnosis. As
the incidence of solitary thyroid nodule is high in Pakistan,
this study will help in early detection of thyroid lesions [8].
Many modalities are used for the diagnosis of solitary
nodule in Pakistan but histopathology remained the gold
standard for the comparison of all. In a recent study it has
been seen that FNAC is a primary investigation of thyroid
lesions and used in a patient with one or more thyroid
nodule. FNAC is also advised for every patient for exclusion
of cancer and in the initial management of patients. It is
frequently used because it is inexpensive, sensitive, speciﬁc,
andanaccurateprocedure;thereforeitisadaptedasaninitial
investigation of thyroid diseases in all tertiary hospitals in
developing countries like Pakistan [9]. In Pakistan, before
performing manual or guided FNAC, thyroid scan and
thyroid function tests (TFTs) are performed for further
management of solitary thyroid nodules. In this study we
compared the individual eﬃcacy of FNAC and thyroid scan
in the management of solitary thyroid nodules. The nodules
were marked after doing their scan by the nuclear center of
Mayo Hospital taking histopathology as gold standard.
2.MaterialandMethods
This was a comparative cross-sectional study and carried
out at the Departments of Surgery, Nuclear Medicine, and
Pathology, King Edward Medical University, Lahore. It was
conducted on 50 patients of solitary thyroid nodule in 06
months.Anonprobabilitypurposivesamplingtechniquewas
used for these patients.
Inclusion Criteria.
(1) Age 10 to 70 Years.
(2) Both genders.
(3) Patient presenting with solitary swelling arising from
any lobe of thyroid selected by clinical palpation.
Exclusion Criteria.
(1) Patients with diﬀuse thyroid swelling.
(2) All toxic and multinodular goitersconﬁrmed by clin-
ical evaluation.
(3) Patients with history of any type of thyroid surgery
(lobectomy or total thyroidectomy).
2.1. Data Collection. All patients presenting with solitary
thyroid nodules in the OPD and fulﬁlling the inclusion crite-
ria wereincludedin thisstudy.Informed consentfrom all the
patientsincludedinthestudywastaken.Allthepatientswere
recorded for their demographic features, that is, age, sex,
Table 1: Distribution of subjects by age and sex.
Age Number Percentage
Male: Female = 9:41 (18% and 82%)
10–20 04 8.0
21–30 22 44.0
31–40 14 28.0
41–50 04 8.0
51–60 05 10.0
61–70 01 2.0
Total 50 100.0
Mean ± SD 33.04± 12.29
Male to female ration 1:4.6
and address (for followup). History of present illness with
regard to symptoms and duration was recorded. They were
examinedforthesignsrelatedtothesolitarythyroidswelling.
All routine investigations and serum T3, T4, and TSH
levelswereperformedbyRadioimmunoassay(RIA),(normal
range of T3, 2.5–5.8pmol/L, T4, 11.5–23.0pmol/L, and
TSH, 0.2–4.0mIU/L). Patients with solitary thyroid swelling
underwent thyroid scan. Solitary thyroid nodules were
selected and then FNAC was performed. The radionuclide
scan and FNA were performed in conjunction as compared
to FNAC alone.
Cytological diagnosis was categorized into four groups:
negative for malignancy, indeterminate (suspicious) for
malignancy, positive for malignancy, and inadequate. The
cases were operated and evaluated for histopathological
changes. The results of thyroid scan, ﬁne needle aspiration
cytology, and histopathology were compared. Histopathol-
ogy was taken as gold standard. All these information were
collected through proforma that is attached herewith.
2.2. Statistical Analysis. All the data was analyzed with SPSS
version 11. The variables included were demographic infor-
mation, routine investigations, thyroid scan, and thyroid
function tests. For quantitative data, that is, thyroid function
tests, duration and size of thyroid nodule, mean, and stan-
dard deviation were calculated. For qualitative data, that is,
results of thyroid scan, ﬁne needle aspiration cytology, and
histopathology, percentages was calculated. A 2×2t a b l ew a s
used to calculate sensitivity, speciﬁcity, positive predictive
value, negative predictive value, and accuracy.
3.Results
The ageofpatientsranged from 10to 70years with mean age
33.04 ± 12.29 years. 41 patients (82%) were females, and 9
(18%) were males (male to female ratio 1:4.6) (Table 1).
Regarding thyroid function tests, 48 patients (96%) were
euthyroid,2patients(4%)werehyperthyroid, andnopatient
w a sh y p o t h y r o i d .T h em e a nf o rs e r u mT 3 ,s e r u mT 4 ,a n d
serum TSH were 4.00 ± 0.90, 16.47 ± 3.18, and 0.95 ± 0.85,
respectively, (normal values given in Table 2). There were
40 patients (80%) who had cold nodule on thyroid scan of
which 8 patients (16%) were male and 32 patients (64%)Pathology Research International 3
Table 2: Distribution of subjects by thyroid function tests (RIA method).
Serum T3 Serum T4 Serum TSH
(2.5–5.8pmol/L) (11.5–23pmol/L) (0.2–4.0mIU/L)
No. %age No. %age No. %age
Normal 48 96.0 48 96.0 48 96.0
Increased 02 4.0 02 4.0 0 0
Decreased 0 0 0 0 02 4.0
Total 50 100.0 50 100.0 50 100.0
Table 3: Distribution of subjects by thyroid scan.
Thyroid scan Male Female Total
No. %age No. %age No. %age
Cold nodule 08 16.0 32 64.0 40 80.0
Hot nodule 01 2.0 09 18.0 10 20.0
Total 09 18.0 41 82.0 50 100.0
Table 4: Distribution of subjects by size of nodule (n = 50).
Size of nodule (cm) Number Benign 44 Malignant6
1–5 35 (70.0%) 32 3
6–10 15 (30.0%) 12 3
>10 0 0 0
Total 50 (100.0%) 44 6
Mean ± SD 4.60 ±1.63
were female, while 10 patients (20%) had hot nodule on
thyroid scan of which 1 patient (2%)was male and 9 patients
(18%) were female (Tables 2 and 3).
The mean for size of thyroid nodule was 4.60 ± 1.63cm.
35 patients (70%) had 1–5cm sized thyroid nodules, and 15
patients(30%) had 6–10cm thyroid nodules. Nopatient had
thyroid nodule greater than 10cm in size (Table 4).
Out of 50 patients, 23 patients (46%) were of benign
FNAC (7 colloid cyst colloid, 2 multinodular goiter, 12
colloid goiter, and 2 chronic lymphocytic thyroiditis). 22
patients (44%) were of indeterminant including suspicious
for malignancy FNAC of which 2 patients (4%) were males
and 20 patients (40%) were females, and 5 patients (10%)
were of malignant FNAC of which 1 patient (2%) was male
and 4 patients (8%) were female. Out of the 23 patients
with benign FNAC, 7 patients (30.4%) had colloid cyst, 2
(8.7%) males and 5 (21.73%) females; 2 patients (8.7%)
had colloid goiter, 1 (4.35%) male and 1 (4.35%) female; 12
patients (52.17%) had colloid nodule, 3 (13.04%) males and
9 (39.13%) females, and 2 patients (8.7%) had lymphocytic
thyroiditis, both females (Tables 4-5).
Out of the 5 patients with malignant FNAC, 3 patients
(60%) had papillary carcinoma, 1 (20%) male and 2 (40%)
females; 1 patient (20%) had medullary carcinoma who was
female, and 1 patient (20%) had anaplastic carcinoma who
was female (Table 4).
Out of the 22 patients with indeterminant FNAC, 3
patients (13.63%) had follicular lesion, all of them females,
and 19 patients (86.37%) had follicular neoplasm, 2 (9.1%)
males and 17 (77.27%) females (Table 4).
On histopathology, 45 patients (90%) were conﬁrmed to
have benign lesions and 5 patients (10%) malignant lesions.
Out of 45 patients with benign lesions on histopathology,
7 patients (15.5%) had colloid cyst, 2 (4.4%) males and
5 (11.1%) females; 2 patients (4.4%) had colloid goiter, 1
(2.2%) male and 1 (2.2%) female; 12 patients (26.67%) had
colloid nodule, 3 (6.67%) males and 9 (20%) females; 2
patients (4.4%) had chronic lymphocytic thyroiditis, both
females; 18 patients (40%) had follicular adenoma, 2 (4.4%)
males and 16 (35.5%) females; 1 patient (2.25%) had diﬀuse
hyperplasia which was female, and 3 patients (6.67%) had
hyperplastic nodule, all of whom were females. Out of 5
patients with malignant lesions on histopathology, 2 patients
(40%) had pure papillary carcinoma, 1 (20%) male and 1
(20%) female; 1 patient (20%) had medullary carcinoma
who was female, 1 patient (20%) had anaplastic carcinoma
who was female, and 1 patient (20%) had angioinvasive
follicular carcinoma (Table 4).
On comparison of results of thyroid scan with histo-
pathology taken as gold standard, out of 50 patients, 4 pa-
tients were true positive, 9 patients true negative, 36 patients
false positive, and one patient false negative (Table 6). The
sensitivity of thyroid scan was found to be 80%, speciﬁcity
20%,diagnosticaccuracy26%,positivepredictivevalue10%,
and negative predictive value 90% (Figure 1 and Table 8).
On comparison of results of FNAC with histopathology
takenasgoldstandard,outof50patients,4patientsweretrue
positive, 44 patients true negative, one patient false positive,
and one patient false negative (Tables 6-7). The sensitivity of
FNAC was 80%, speciﬁcity 97.7%, diagnostic accuracy 96%,
positive predictive value 80%, and negative predictive value
97.7% (Table 8).
Morphological comparison of diﬀerent lesions on FNAC
and Histopathology is shown in Figures 2–5.
4.Discussion
Fine needle aspiration cytology is a well-established tech-
nique for preoperative investigation of thyroid nodules.
The technique is a noninvasive, cost-eﬀective, and eﬃcient4 Pathology Research International
Table 5: Distribution of subjects by benign and malignantlesions FNAC and histopathology.
Classiﬁcation (benign = 23 and malignant = 5) FNAC (n = 50) Histopathology (n = 50)
Colloid cyst 07 (30.43%) 7 (14%)
Multi nodular colloid goitre 02 (8.70%) 2 (4%)
Colloid goiter 12 (52.17%) 12 (24%)
Chroinic lymphocytic thyroiditis 02 (8.70%) 2 (4%)
Follicular lesions (neoplasm) 21 Nil
Follicular adenoma — 18 (36%)
Diﬀuse hyperplasia — 1 (2%)
Hyperplastic nodule — 3 (6%)
Papillary carcinoma 03 (60.0%) 2 (4%)
Medullary carcinoma 01 (20.0%) 1 (2%)
Anaplastic carcinoma 01 (20.0%) 1 (2%)
Folicular carcinoma — 1 (2%)
Table 6: Distribution of subjects by classiﬁcationof FNAC n = 50.
Classiﬁcation
FNAC
Histopathology Male Female Total
No. No.
Benign 06 (12.0%) 17 (34.0%) 23 (46.0%) 44 (88%)
Malignant 01 (2.0%) 04 (8.0%) 05 (10.0 %) 06 (12%)
Indeterminant 02 (4.0%) 20 (40.0%) 22 (44.0%) —
Total 09 (18.0%) 41(82.0%) 50 (100.0%) 50 (100%)
Table 7: Comparison of distribution of subjects by classiﬁcationof
FNAC and histopathology.
Classiﬁcation FNAC Histopathology
Benign 23 (46 %) 44 (88%)
Malignant 05 (10%) 06 (12%)
Indeterminant 22 (44%) —
Total 50 (100%) 50 (1005)
0
20
40
60
80
100
Sensitivity
Speciﬁcity PPV NPV
Accuracy
Thyroid scan
FNAC
Figure 1: Comparison of sensitivity, speciﬁcity, positive predictive
value, negative predictive value and diagnostic accuracy of thyroid
scan and ﬁne needle aspiration cytology.
method of diﬀerentiating benign and malignant thyroid
nodules [1, 10, 11]. Many investigators have shown that
ﬁne needle aspiration cytology is the single most sensitive,
speciﬁc, and cost-eﬀective method in the investigation of
solitary thyroid nodules [12, 13]. Despite studies supporting
thecost-eﬀectivenessofﬁneneedle aspirationcytologyasthe
diagnostic test of choice, I-131 scintigraphy continues to be
used by frontline providers as primary diagnostic tools in
the management of patients with nodular thyroid diseases.
Justiﬁcations for the continued use of this alternative diag-
nostic strategyusuallyrangefrom historical practicepatterns
within institutionstofasterturnaroundtimeforresultswhen
compared with waiting for FNAC pathology reports. FNAC
of thyroid is gaining popularity among pathologists and
clinicians all over the world [14–17].
In our study, the age of patients ranged from 10 to 70
years with mean age 33.04±12.29years. The highest number
of patients was aged between 21–30 years, that is, 22 (44%).
In a study from Saudi Arabia, the mean age was 36.17 ± 12.3
years (range 15–67 years) which is very close to our study
[18]. In this study, the female to male ratio was high. In our
study, out of 50 patients 41 (82%) were females and only 9
(18%) were males. Female to male ratio was 5.2:1. These
results are close to Hussain and Anwar, who found female
to male ratio as 6.9:1 [3] .I no u rs t u d y ,4 0p a t i e n t s( 8 0 % )
had cold nodule on thyroid scan. 10 patients (20%) had
hot nodule on thyroid scan. In a study from India, 77.77%
patients had cold nodule on thyroid scan while 22.22%
patients had hot nodule on thyroid scan, which is close to
our study [19].
In the literature, it is clearly indicated that the nodule
size is only a weak predictor of histological malignancy [12].
In our study, 35 patients (70%) had 1–5cm sized thyroidPathology Research International 5
Table 8: Comparison of thyroid scan and FNAC with histopathology.
Thyroid scan and histopathology Total FNAC and histopathology (n = 50) Total
Positive Negative Positive Negative
Positive 04 (TP) 36 (FP) 40 04 01 05
Negative 01 (FN) 09 (TN) 10 01 44 45
T o t a l 0 54 5 5 0 0 54 55 0
Sensitivity = 80%, speciﬁcity = 20%, accuracy 26%, PPV = 10%, and
NPV = 90%
Sensitivity = 80.0%, speciﬁcity = 97.7%, accuracy = 96.0%,
PPV = 80.0%, and NPV = 97.7%
(a) (b)
(c) (d)
Figure 2: Photomicrograph of FNAC (a) and (b) (H&E) follicular neoplasms, showing marked cellularity, discohesion, single cells,
Predominantly microfollicles and/or trabeculae, uniformly enlarged cells, crowding, scant colloid, marked nuclear atypia, mitosis and
necrosis is uncommon. (c) Histopathology (H&E 10x) of follicular carcinoma showing capsular (thin arrow) and vascular invasion (thick
arrow). (d) Follicular adenoma, (H&E 10x) where no capsular invasion is seen while histologic evidence of invasion is the gold standard of
malignancyfor the follicular lesions.
nodulesand 15patients(30%)had 6–10cmthyroidnodules.
The rate of malignancy was almost the same in our data, and
the chances of malignancy were independent of its size. Our
ﬁndings are consistent with other studies [20].
After comparison of our results of thyroid scan with his-
topathology, overall sensitivity of thyroid scan was found
to be 80%, speciﬁcity 20%, positive predictive value 10%,
and negative predictive value 90%. The overall accuracy
was 26%. In one study of thyroid scan, it was reported to
have sensitivity 100% and speciﬁcity 24% which is close
to our study [19]. This shows that thyroid scan is more
sensitive than speciﬁc in detecting thyroid malignancy. In
our study, 23 patients (46%) were of benign FNAC. 22
patients (44%) were of indeterminant FNAC. 5 patients
(10%) were of malignant FNAC. In a study from Pakistan,
39.47% of patients were of benign FNAC, 43.42% were of
indeterminant FNAC, and 11.84% were of malignant FNAC,
which is very close to our study [9].
Out of the 23 patients with benign FNAC, 7 patients
(14%) had colloid cyst, 2 patients (4%) had colloid goiter,6 Pathology Research International
(a) (b)
(c) (d)
Figure 3: (a) and (b) PhotomicrographonFNAC (Pap) of medullary carcinoma with isolated, loosely cohesive, syncytial fragments,round,
oval, cuboidal, plasmacytoid, spindle, round, multinucleated, nuclear inclusions and pale, ﬁbrillar, calcitonin granules and extracellular
amyloid. (c) Histopathology (10x H&E) of same case and (d) Congo red positivity.
12 patients (24%) had colloid nodule, and 2 patients (4%)
had lymphocytic thyroiditis. All the patients with benign
FNAC were conﬁrmed to have the same results on histo-
pathology. Out of the 22 patients with indeterminant FNAC,
3 patients (6%) had follicular lesion and 19 patients (38%)
had follicular neoplasm. On histopathology, all 3 patients
with follicular lesions were conﬁrmed to have hyperplastic
nodule, and out of the 19 patients with follicular neoplasm,
18patients(36%)wereconﬁrmedtohavefollicularadenoma
whereas 1 patient (2%) had follicular carcinoma. The inter-
mediate ﬁndings were the main pitfalls of FNAC thyroid.
This could be due to overdiagnosis on cytological reporting
[9]. Our ﬁndings are consistent with Flanagan et al. [21].
Out of the 5 patients with malignant FNAC, 3 patients
(6%) had papillary carcinoma (Figure 3), 1 patient (2%)
had medullary carcinoma (Figure 2), and 1 patient (2%) had
anaplastic carcinoma (Figure 4). On histopathology, out of
3 patients with papillary carcinoma, 2 patients (4%), were
conﬁrmed to have papillary carcinoma whereas 1 patient
had diﬀuse hyperplasia. Patients with medullary carcinoma
and anaplastic carcinoma on FNAC were found to have
the same on histopathology. Therefore, in this study the
concordance between the malignant FNAC diagnosis and
histologic followup was 80%; this is comparable to other
studies in the literature [9, 21–25].
FNAC is a sensitive and highly speciﬁc method of eval-
uating thyroid nodules for malignancy [22–25]. After com-
parison of our results of FNAC with histopathology, overall
sensitivity of FNAC was 80%, speciﬁcity 97.7%, positive
predictive value 80%, and negative predictive value 97.7%.
The overall accuracy was 96%. Our results are consistent
with results of other studies. In a review on FNAC of the
thyroid nodule, it was reported to have sensitivity of 65–98%
and a speciﬁcity of 72–100% [26–28]. In another study, the
analysis of data revealed a sensitivity of 88.9% and speciﬁcity
of 96.1% with diagnostic accuracy of 94.2%. This shows that
FNAC is more speciﬁc than sensitive in detecting thyroid
malignancy, and therefore, it is used as a reliable diagnostic
test [1].
The false negative rate (FNR) is deﬁned as the percentage
of patients with benign cytology in whom malignant lesions
arelaterconﬁrmedonhistopathology.Ourresultsaboutfalse
positive and false negative rates are consistent with the pub-
lished guidelines of Papanicoloau society of cytopathology
[29–31]. This guideline suggested that a false negative and
false positive rate of < 2 %a n d3 % ,r e s p e c t i v e l y ,s h o u l db ePathology Research International 7
(a) (b)
(c) (d)
Figure 4:(a),(b),and (c) Photomicrographsofpapillary carcinomashowinghypochromasia/pallor,nuclear grooves, intranuclear cytoplas-
mic inclusions,ovoid nucleus, and micronucleolus. (d) Histopathology of papillary cell carcinoma.
achieved [29]. In series of studies, FNRwas reported ranging
from 1.5% to 11.5% [32]. Ashcraft and van Herle noted that
FNR results varied in reported series from 2% to 50% and
that among 1330 patients, all of whom had a histological
examination, the FNR was 1.7% [33]. In our series, we
reported one case as false negative that translated to 2%
FNR. This case was however conﬁrmed on histopathology
as follicular carcinoma. Our value is consistent with other
studies of Boey and colleagues [34].
The false positive rate (FPR) indicates that a patient with
malignant FNAC result was found on histological exami-
nation to have benign lesion. Caruso and Mezzaferri [32]
reportedlessthan6%FPRwhileCampbellandPillsbury[35]
reported 1.2%. In our series, we reported 1 case as malignant
on FNAC but it turned out to be diﬀuse hyperplasia on
histopathology. The FPR is 2%, which agreed with other
series that range 0–8%.
The overall accuracy for FNAC was 96%, which agrees
with other studies of 95% [32]. In our study, sensitivity
of FNAC was 80%, which was equivalent to the sensitivity
of thyroid scan. However, speciﬁcity of FNAC was 97.7%
compared to only 20% for thyroid scan. The very low
speciﬁcityofthyroidscan mightmakeitappearasasuperﬂu-
ous investigation compared to FNAC. The overall accuracy
of FNAC was 96% while that of thyroid scan was only
26%.These ﬁndings are consistent with the data found
worldwide [19].
In Pakistan as a routine matter, the evaluation of thyroid
is carried out with FNA, the ultrasonography, and scanning
with 131I and 99Tc. But before this procedure thyroid scans
was the most common test in our setup, used to identify
“hot” and “cold” lesions. Hot or warm nodules, about 5%,
are seldom malignant, whereas cold or hypofunctional have
10% to 25% chances of being malignant. With the introduc-
tion of FNA, people are more relying on this procedure as
an elected laboratory test: because it is easy, simple, non-
traumatic, and very acceptable to the patients. We cannot
undermine the usefulness.
FNAC should be advised for every patient for exclusion
of cancer. As FNAC is an inexpensive, sensitive, speciﬁc, and
accurate procedure, it should be adapted as an initial in-
vestigation of thyroid diseases in all tertiary hospitals in
developing countries like Pakistan.
5.Conclusion
Fineneedleaspirationcytologyismorespeciﬁcthansensitive
whereas thyroidscan is more sensitivethan speciﬁc indetect-
ing thyroid malignancy. Fine needle aspiration cytology is
highlyaccurateandbetterthanthyroidscanintheevaluation8 Pathology Research International
(a) (b)
(c) (d)
Figure 5: (a) Photomicrograph on FNAC (Pap stain 40x), anaplastic carcinoma showing pleomorphism in size and shape with giant
or multinucleate forms, prominent nucleoli, nuclear inclusions, and vacuolated cytoplasm. (b) Histopathology (10x H&E) of anaplastic
carcinoma. (c) FNAC (Pap stain 20x) of colloid goiter showing macrophages and uniform cuboidal cells of thyroid follicles. (d)
Histopathology of colloid goiter (H&E 40x).
of solitary thyroid nodule. Therefore, FNAC should be
adapted as an initial investigation of thyroid diseases in all
tertiary hospitals. The information provided by thyroid scan
has no signiﬁcant bearing in the management of solitary
thyroid nodule. FNAC provides useful information and may
be used along with other clinical information to decide best
form of treatment in a solitary thyroid nodule. The use
of FNAC has reduced the number of patients with solitary
thyroid nodules undergoing unnecessary surgery and has led
to proper planning of surgery in malignant cases.
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